Ownership

Joel Lewis - President and CEO, Director at Galectin Therapeutics Inc

Insider Transactions and Holdings

Entity Type: Individual
Role: President and CEO, Director
Stock Symbol: GALT on Nasdaq
Industry: Pharmaceutical Preparations
All Insider Reports: All Insider Reports

Joel Lewis - trading volume in the past year for Galectin Therapeutics Inc

	Shares	%	Avg Price	Total $
Buys	+1K	1.8%	$3.39	+$3.39K
Sells	-56K	98.2%	$0.89	-$49.6K
Net	-55K	-96.5%		-$46.2K

Holdings reported by Joel Lewis for Galectin Therapeutics Inc

Security	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	833K	$1.31M	$1.57	Mar 3, 2025	Direct
Restricted Stock Unit	84K	$97.4K	$1.16	Jan 23, 2025	Direct	Common Stock
Common Stock	2K	$3.14K	$1.57	Mar 3, 2025	as USTA custodian for a minor child
Restricted Stock Units	0	$0	$0.82	Dec 23, 2024	Direct	Common Stock
Stock Option (right to buy)	91K			Jan 23, 2025	Direct	Common Stock

Transactions reported by Joel Lewis for Galectin Therapeutics Inc

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.